Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Posted on by

The Lancet
Dec 04, 2021 Volume 398 Number 10316 p2051-2124
https://www.thelancet.com/journals/lancet/issue/current

 

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Noam Barda, et al.